Although the functional connection between high NET levels and C5a has been well described (Yousefi et al., 2009; Huang et al., 2015; Yuen et al., 2016; Fattahi et al., 2018; de Bont et al., 2019), it has never been explored in AD. Here, C5 is linked to Alzheimer disease.